Clinical features of six patients with catecholaminergic polymorphic ventricular tachycardia.
- Author:
Dong-sheng ZHAO
1
;
Jian-hua SHEN
;
Jing-ping LU
;
Sheng-yong YU
;
Gang ZHANG
;
Jie GENG
;
Qi-jun SHAN
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Catecholamines; adverse effects; Child; Electrocardiography; Female; Humans; Male; Tachycardia, Ventricular; diagnosis; physiopathology; Young Adult
- From: Chinese Journal of Cardiology 2012;40(10):844-848
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo describe the clinical features of 6 patients with catecholaminergic polymorphic ventricular tachycardia.
METHODSClinical data including signs and symptoms, electrocardiograms, Holter monitoring electrocardiograms and echocardiography was analyzed. Definite diagnosis was made based on the mutations of RYR2 and CASQ2.
RESULTSFrom July 2002 to March 2010, 6 consecutive patients referred to our center because of syncope [4 males, mean age (13.0 ± 4.2) years] were diagnosed with CPVT by clinical evaluation and genetic testing. Their electrocardiograms showed T waves with notch or bimodal and tall U waves in right chest leads. There was no J wave, no ST-segment deviation, no prolongation or shortening of QT interval. We captured the so-called "bidirectional and(or) polymorphic ventricular tachycardia (bVT and pVT)" in 2 out of 6 patients by ECG, in 5 out of 6 patients by 24-hours Holter monitor, in 3 out of 6 patients by exercise test. All patients received β blockers and no syncope occurred during the 3 months follow-up after discharge from hospital.
CONCLUSIONSCPVT is an inherited cardiac channelopathy characterized by syncope and(or) sudden death relatived to motion. The ECG shows T wave alteration and tall U wave in right chest leads. The mode of its onset is bVT and(or) pVT, and can be captured by Holter easily. β blocker is a safe and effective remedy for suppressing its attack.